CytomX Therapeutics Inc (NASDAQ:CTMX)

BATS BZX Real-Time Price
As of 1:49pm ET
 -0.03 / -2.04%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for CytomX Therapeutics Inc have a median target of 3.25, with a high estimate of 8.00 and a low estimate of 1.63. The median estimate represents a +125.69% increase from the last price of 1.44.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Hold stock in CytomX Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.61%
Growthannually 4.02%


Growthquarterly -0.06%
Growthannually 6.75%
Key to the earnings and sales forecast charts.